USA - NYSE:CBT - US1270551013 - Common Stock
The current stock price of CBT is 69.08 USD. In the past month the price decreased by -8.24%. In the past year, price decreased by -36.64%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| DOW | DOW INC | N/A | 17.62B | ||
| LYB | LYONDELLBASELL INDU-CL A | 13.05 | 15.02B | ||
| WLK | WESTLAKE CORP | 68.66 | 9.42B | ||
| HWKN | HAWKINS INC | 39.06 | 3.31B | ||
| MEOH | METHANEX CORP | 7.2 | 2.63B | ||
| OLN | OLIN CORP | 31 | 2.45B | ||
| PCT | PURECYCLE TECHNOLOGIES INC | N/A | 2.19B | ||
| BAK | BRASKEM SA-CLASS A- ADR | N/A | 1.04B | ||
| WLKP | WESTLAKE CHEMICAL PARTNERS L | 12.72 | 667.80M | ||
| MATV | MATIV HOLDINGS INC | 24.2 | 595.36M | ||
| TROX | TRONOX HOLDINGS PLC | N/A | 577.01M | ||
| KRO | KRONOS WORLDWIDE INC | 245.5 | 564.90M |
Cabot Corp. is a global specialty chemicals and performance materials company. The company is headquartered in Boston, Massachusetts and currently employs 4,200 full-time employees. The firm's principal products are reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, inkjet colorants and aerogel. The company operates through two segments: Reinforcement Materials and Performance Chemicals. Its reinforcing carbon products are used in tires and industrial products. In addition to its reinforcing carbons, it manufactures engineered elastomer composites (E2C) solutions that are composites of reinforcing carbons and rubber made using its patented elastomer composites manufacturing process. Under Performance Chemicals segment, it designs, manufactures and sells materials that deliver performance in a range of customer applications across the automotive, construction, infrastructure, inkjet printing, electronics, and consumer products sectors and in applications related to the generation, transmission and storage of energy.
CABOT CORP
Two Seaport Lane Suite 1400
Boston MASSACHUSETTS 02210 US
CEO: Sean D. Keohane
Employees: 4200
Phone: 16173450100
Cabot Corp. is a global specialty chemicals and performance materials company. The company is headquartered in Boston, Massachusetts and currently employs 4,200 full-time employees. The firm's principal products are reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, inkjet colorants and aerogel. The company operates through two segments: Reinforcement Materials and Performance Chemicals. Its reinforcing carbon products are used in tires and industrial products. In addition to its reinforcing carbons, it manufactures engineered elastomer composites (E2C) solutions that are composites of reinforcing carbons and rubber made using its patented elastomer composites manufacturing process. Under Performance Chemicals segment, it designs, manufactures and sells materials that deliver performance in a range of customer applications across the automotive, construction, infrastructure, inkjet printing, electronics, and consumer products sectors and in applications related to the generation, transmission and storage of energy.
The current stock price of CBT is 69.08 USD. The price decreased by -2.7% in the last trading session.
CABOT CORP (CBT) has a dividend yield of 2.53%. The yearly dividend amount is currently 1.7.
CBT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
CBT stock is listed on the New York Stock Exchange, Inc. exchange.
The next ex-dividend date for CABOT CORP (CBT) is August 29, 2025.
The outstanding short interest for CABOT CORP (CBT) is 3.09% of its float.
ChartMill assigns a fundamental rating of 7 / 10 to CBT. CBT gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months CBT reported a non-GAAP Earnings per Share(EPS) of 7.36. The EPS increased by 6.51% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.96% | ||
| ROA | 10.89% | ||
| ROE | 27.13% | ||
| Debt/Equity | 0.78 |
9 analysts have analysed CBT and the average price target is 89.76 USD. This implies a price increase of 29.94% is expected in the next year compared to the current price of 69.08.
For the next year, analysts expect an EPS growth of 3.48% and a revenue growth -5.83% for CBT